Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut-derived macrophages as endogenous carriers for brain-targeted cisplatin nanotherapy.

Biomaterials·2026
Same author

Failed resolution of inflammation in intracerebral haemorrhage.

Nature reviews. Neurology·2026
Same author

GATA1 repression-mediated ADRB2/cAMP/PKA signaling activation underlies the antidepressant effects of targeted geniposide delivery.

Cell death discovery·2026
Same author

Metabolic Collapse in Acute CNS Injury: A Spatiotemporal Framework Linking Redox Failure, Ferroptosis, and Neurovascular Dysfunction.

Antioxidants & redox signaling·2026
Same author

A sustained-release depot formulation of β-nicotinamide mononucleotide for alleviating chemotherapy-induced myelosuppression.

Materials today. Bio·2026
Same author

Engineering RVG-modified exosomes for targeting TGF-β1 signaling in stroke recovery.

Journal of translational medicine·2026

Related Experiment Video

Updated: Aug 12, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.7K

Customizing delivery nano-vehicles for precise brain tumor therapy.

Yang-Bao Miao1,2, Wang Zhao3,4, Gao Renchi3,4

  • 1Department of Haematology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine of University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu, 610000, China. miaoyangbao@gmail.com.

Journal of Nanobiotechnology
|January 28, 2023
PubMed
Summary

Nanotechnology offers new ways to deliver drugs across the blood-brain barrier (BBB) for brain tumor treatment. Customizing nanoparticles enhances drug delivery efficacy for improved outcomes.

Keywords:
Blood–brain barrierCentral nervous systemDrug deliveryNanoparticleTumor

More Related Videos

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

16.0K
Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model
09:57

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Published on: June 4, 2017

12.3K

Related Experiment Videos

Last Updated: Aug 12, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.7K
Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

16.0K
Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model
09:57

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Published on: June 4, 2017

12.3K

Area of Science:

  • Neuroscience
  • Oncology
  • Nanotechnology

Background:

  • Central nervous system (CNS) involvement remains a significant challenge in cancer treatment.
  • The blood-brain barrier (BBB) poses a major obstacle for delivering therapeutics to brain tumors.
  • Nanotechnology presents promising strategies for overcoming the BBB.

Purpose of the Study:

  • To review the causes of brain tumor formation and the characteristics of the BBB.
  • To discuss various nanocarriers and strategies for crossing the BBB for anti-brain tumor drug delivery.
  • To explore the potential of customized nanoparticles for enhancing brain tumor treatment efficacy.

Main Methods:

  • Comprehensive review of existing literature on brain tumors, BBB, and nanotechnology-based drug delivery.
  • Elucidation of the complex compositions and characteristics of brain tumors and the BBB.
  • Discussion of diverse nanocarrier systems and their mechanisms for BBB penetration.

Main Results:

  • Nanoparticles (NPs) demonstrate potential in crossing the BBB through various strategies.
  • Understanding BBB properties is crucial for designing effective drug delivery systems.
  • Customizing nanoparticle characteristics can facilitate drug distribution across the brain.

Conclusions:

  • Nanotechnology-based drug delivery holds significant promise for treating brain tumors.
  • Tailoring nanoparticle properties is key to improving drug delivery across the BBB.
  • Further development of innovative nanotechnology-based nanomaterials is essential for advancing brain tumor therapies.